The aberrant expression of CD180 in disease is also accompanied by functional differences, particularly in CLL where the receptor has apparently unique signaling properties which can powerfully regulate CLL cell behaviour and the action of the BCR. Here, BCR is linked to B-cell chronic lymphocytic leukemia.